BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36905405)

  • 21. Metabolically healthy obesity without fatty liver and risk of incident type 2 diabetes: A meta-analysis of prospective cohort studies.
    Hashimoto Y; Hamaguchi M; Tanaka M; Obora A; Kojima T; Fukui M
    Obes Res Clin Pract; 2018; 12(1):4-15. PubMed ID: 29307656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of metabolically healthy obesity in primary infertile men: Results from a cross-sectional study.
    Cazzaniga W; Candela L; Boeri L; Capogrosso P; Pozzi E; Belladelli F; Baudo A; Ventimiglia E; Alfano M; Abbate C; Montorsi F; Salonia A
    Andrology; 2020 Nov; 8(6):1762-1769. PubMed ID: 32644296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irinotecan decreases intestinal UDP-glucuronosyltransferase (UGT) 1A1 via TLR4/MyD88 pathway prior to the onset of diarrhea.
    Tao G; Dagher F; Li L; Singh R; Hu M; Ghose R
    Food Chem Toxicol; 2022 Aug; 166():113246. PubMed ID: 35728726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study.
    Gutiérrez-Repiso C; Soriguer F; Rojo-Martínez G; García-Fuentes E; Valdés S; Goday A; Calle-Pascual A; López-Alba A; Castell C; Menéndez E; Bordiú E; Delgado E; Ortega E; Pascual-Manich G; Urrutia I; Mora-Peces I; Vendrell J; Vázquez JA; Franch J; Girbés J; Castaño L; Serrano-Ríos M; Martínez-Larrad MT; Catalá M; Carmena R; Gomis R; Casamitjana R; Gaztambide S
    Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):947-55. PubMed ID: 24984822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of proinflammatory genes expression with serum interleukin 1β and free fatty acids in metabolically healthy and unhealthy abdominally obese individuals: a case-control study.
    Amiri P; Baradaran B; Saghafi-Asl M; Naghizadeh M; Shanehbandi D; Karamzad N; Vahed SZ
    BMC Immunol; 2019 Jul; 20(1):23. PubMed ID: 31272370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular Risk Factors Associated With the Metabolically Healthy Obese (MHO) Phenotype Compared to the Metabolically Unhealthy Obese (MUO) Phenotype in Children.
    Genovesi S; Antolini L; Orlando A; Gilardini L; Bertoli S; Giussani M; Invitti C; Nava E; Battaglino MG; Leone A; Valsecchi MG; Parati G
    Front Endocrinol (Lausanne); 2020; 11():27. PubMed ID: 32117055
    [No Abstract]   [Full Text] [Related]  

  • 27. TLR2, TLR4 AND MyD88 Mediate Allergic Airway Disease (AAD) and Streptococcus pneumoniae-Induced Suppression of AAD.
    Thorburn AN; Tseng HY; Donovan C; Hansbro NG; Jarnicki AG; Foster PS; Gibson PG; Hansbro PM
    PLoS One; 2016; 11(6):e0156402. PubMed ID: 27309732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary patterns and physical activity in the metabolically (un)healthy obese: the Dutch Lifelines cohort study.
    Slagter SN; Corpeleijn E; van der Klauw MM; Sijtsma A; Swart-Busscher LG; Perenboom CWM; de Vries JHM; Feskens EJM; Wolffenbuttel BHR; Kromhout D; van Vliet-Ostaptchouk JV
    Nutr J; 2018 Feb; 17(1):18. PubMed ID: 29433580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonistic Property of G2013 (α-L-Guluronic Acid) on Gene Expression of MyD88, Tollip, and NF-κB in HEK293 TLR2 and HEK293 TLR4.
    Sharifi L; Aghamohammadi A; Aletaha S; Bigdeli R; Asgary V; Bokaie S; Asgardoon MH; Azizi G; Mirshafiey A
    Endocr Metab Immune Disord Drug Targets; 2019; 19(2):144-149. PubMed ID: 30784390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolically healthy obesity is associated with higher risk of both hyperfiltration and mildly reduced estimated glomerular filtration rate: the role of serum uric acid in a cross-sectional study.
    Zhang H; Chen R; Xu X; Yang M; Xu W; Xiang S; Wang L; Jiang X; Hua F; Huang X
    J Transl Med; 2023 Mar; 21(1):216. PubMed ID: 36959674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRAM is required for TLR2 endosomal signaling to type I IFN induction.
    Stack J; Doyle SL; Connolly DJ; Reinert LS; O'Keeffe KM; McLoughlin RM; Paludan SR; Bowie AG
    J Immunol; 2014 Dec; 193(12):6090-102. PubMed ID: 25385819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolically healthy obesity increased diabetes incidence in a middle-aged and elderly Chinese population.
    Wei Y; Wang J; Han X; Yu C; Wang F; Yuan J; Miao X; Yao P; Wei S; Wang Y; Liang Y; Zhang X; Guo H; Zheng D; Tang Y; Yang H; He M
    Diabetes Metab Res Rev; 2020 Jan; 36(1):e3202. PubMed ID: 31291052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of TLR2 and TLR4 in inflammatory immune responses induced by fine and coarse ambient air particulate matter.
    Shoenfelt J; Mitkus RJ; Zeisler R; Spatz RO; Powell J; Fenton MJ; Squibb KA; Medvedev AE
    J Leukoc Biol; 2009 Aug; 86(2):303-12. PubMed ID: 19406832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variations in the prevalence and predictors of prevalent metabolically healthy obesity in adolescents.
    Heinzle S; Ball GD; Kuk JL
    Pediatr Obes; 2016 Oct; 11(5):425-33. PubMed ID: 26643813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR2 and TLR4 mediate differential responses to limb ischemia through MyD88-dependent and independent pathways.
    Sachdev U; Cui X; McEnaney R; Wang T; Benabou K; Tzeng E
    PLoS One; 2012; 7(11):e50654. PubMed ID: 23209800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Youth to adult body mass index trajectories as a predictor of metabolically healthy obesity in adulthood.
    Smith KJ; Magnussen CG; Pahkala K; Koskinen J; Sabin MA; Hutri-Kähönen N; Kähönen M; Laitinen T; Tammelin T; Tossavainen P; Jokinen E; Viikari JSA; Juonala M; Raitakari OT
    Eur J Public Health; 2020 Feb; 30(1):195-199. PubMed ID: 31169878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa.
    Skerrett SJ; Wilson CB; Liggitt HD; Hajjar AM
    Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L312-22. PubMed ID: 16936244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of Toll-like receptor 4 in high-glucose-induced inflammatory and fibrosis markers in human peritoneal mesothelial cells.
    Choi SY; Ryu HM; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    Int Urol Nephrol; 2017 Jan; 49(1):171-181. PubMed ID: 27722989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TLR-dependent control of Francisella tularensis infection and host inflammatory responses.
    Abplanalp AL; Morris IR; Parida BK; Teale JM; Berton MT
    PLoS One; 2009 Nov; 4(11):e7920. PubMed ID: 19936231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.